Parvovirus B19: a review

Katta, Rajani

doi:10.1016/s0733-8635(01)00013-4

Cited by 48 publications

(45 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[9] Often lymphopenia and temporary anemia are seen in laboratory tests, with a less than often elevation in liver enzymes. [8] We did not find any anemia, lymphopenia, or biochemical abnormality in our patient. This syndrome limits itself to a period of 7-14 days.…”

Section: Discussioncontrasting

confidence: 41%

See 1 more Smart Citation

An Adult Patient who Presented to Emergency Service with a Papular Purpuric Gloves and Socks Syndrome: A Case Report

Ozaydin¹,

Eceviz²,

Doğan³

et al. 2014

Tr J Emerg Med

View full text Add to dashboard Cite

SUMMARYRash diseases characterized macules, papules, vesicles and pustules. Many viral infection associated with generalized morbilliform skin rash. Papular purpuric gloves and socks syndrome (PPGSS) is a clinical situation caused by human parvovirus B19. PPGSS occurs at hands and foot through lesions exhibiting symmetrical gloves and socks-like erythematous dispersion. Concomitantly, there are lesions and fever at mouth. A 35 years old woman applied with papular symmetrical eruption at hands and foot, oral lesions and fever. There existed symmetrical rashes at hands and foot and lesions in mouth during her physical examination. Parvovirus İg M positive were determined.The patient who was administered symptomatic treatment was externalized.

show abstract

Section: Discussioncontrasting

confidence: 41%

“…Mucosal findings include petechia, pharyngeal erythema, swollen lips, and painful oral aphthous lesions. [8] Vulvar edema and erythema as well as dysuria have also been described. [9] Often lymphopenia and temporary anemia are seen in laboratory tests, with a less than often elevation in liver enzymes.…”

Section: Discussionmentioning

confidence: 99%

An Adult Patient who Presented to Emergency Service with a Papular Purpuric Gloves and Socks Syndrome: A Case Report

Ozaydin¹,

Eceviz²,

Doğan³

et al. 2014

Tr J Emerg Med

View full text Add to dashboard Cite

show abstract

“…Parvovirus B19, a small, single-stranded, nonenveloped DNA virus, is a human pathogen that can result in a wide array of clinical findings [1,2]. It is resistant to heat, cold, and solvents.…”

Section: Introductionmentioning

confidence: 99%

“…The peak incidence rates occur in 6-to 14-year-old children. The immunity prevalence to parvovirus increases with age and may be greater than 60% by adulthood [1]. Infection is most frequently found in the late winter or early spring [5].…”

Section: Introductionmentioning

confidence: 99%

Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients

Obeid

2011

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: Parvovirus B19 is a cause of hemolysis and red blood cell aplasia in patients with sickle cell anemia. The present study aimed to assess parvovirus B19 infection among sickle cell anemia patients. Methodology: All patients (n = 138) included in the study were sickle cell anemia patients. Blood donors were used as a control group. Assessment of parvovirus B19 antibodies and viral DNA was performed using established methods of detection and B19 recomBlot assay. Results: Detectable levels of parvovirus B19 IgG were found in 52 samples (37.6%) whereas anti-parvovirus B19 IgM antibodies were detected in four (2.89 %) patients of the sickle-cell anemia group. Anti-B19 IgM-positive samples contained B19-viral DNA. These four patients presented with fever, malaise, pallor and no cutaneous rash. Anti-parvovirus B19 antibodies were detected in 22 (39.3%) of the control blood donors group. Anti-parvovirus B19 IgM antibodies were not detected in the control group. Using the recomBlot assay, 58 test samples (42%) were found to contain detectable levels of Parvovirus B19 antibodies. All the samples that were positive for parvovirus B19 IgG by the ELISA were also positive by the recomBlot assay. Six samples were only positive by the recomBlot assay and not by the ELISA. Two of these six samples were positive for B19 viral DNA. Conclusions: Establishing the extent of parvovirus B19 infection in sickle cell anemia patients will help in proper management of aplastic crisis in such patients. The B19 recomBlot assay may be suitable as a confirmatory assay.

show abstract

“…Ritkábban kevésbé típusos tünetek, kismértékben infiltrált plakkok, vesiculák, viszketés, a buccalis nyálkahártyán és a szájpadon enanthema jelentkezhet. A bőrtüneteket lázzal, gyengeséggel, izom és ízületi fájda-lommal, fejfájással járó prodróma előzheti meg (13,14). Gyermekek esetén a fertőzést követően ritkán, az esetek 10-15 %-ában jelentkezik arthritis, míg a felnőtt női populációban az exanthema mellett az ízületi panaszok gyakorisága a 60 %-ot is elérheti (8,15).…”

Section: Human Parvovírus B19unclassified